Afinitor (everolimus) is an mTOR inhibitor that treats various cancers including advanced breast cancer, kidney cancer, neuroendocrine tumors, and brain tumors associated with tuberous sclerosis by blocking proteins that help cancer cells grow. For patients seeking online medicine shopping options, working with oncology specialists and licensed providers ensures proper monitoring for this targeted cancer therapy requiring regular blood tests and close medical supervision throughout treatment.
Casodex (bicalutamide) is a non-steroidal anti-androgen for treating Stage D2 metastatic prostate cancer in combination with LHRH hormone therapy. This androgen receptor inhibitor blocks testosterone effects on cancer cells. Requires oncologist or urologist specialist supervision with regular monitoring for liver function and treatment effectiveness throughout therapy.
Lynparza (olaparib) is an oral PARP inhibitor used to treat various cancers with DNA repair deficiencies, including BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. This targeted therapy blocks an enzyme that helps repair DNA in cancer cells, causing tumor cell death while sparing normal cells. For patients seeking advanced cancer treatment options, working with oncologists ensures proper genetic testing and monitoring, as Lynparza requires careful medical supervision due to potential serious side effects including bone marrow suppression, lung inflammation, and blood clotting complications that necessitate regular blood monitoring and specialized cancer care throughout treatment.
Prolia and Xgeva both contain denosumab, a human monoclonal antibody that prevents bone breakdown by blocking RANK Ligand. While the medications share the same active ingredient, they're formulated at different doses for distinct therapeutic purposes.
When you buy medications online from Tel Aviv Pharma, you receive authentic denosumab products at prices significantly lower than traditional pharmacies, with convenient worldwide shipping directly to your healthcare provider.